Department of Health and Human Services November 8, 2012 – Federal Register Recent Federal Regulation Documents

Decision To Evaluate a Petition To Designate a Class of Employees From the Battelle Laboratories King Avenue Facility in Columbus, OH, To Be Included in the Special Exposure Cohort
Document Number: 2012-27346
Type: Notice
Date: 2012-11-08
Agency: Department of Health and Human Services
NIOSH gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees from the Battelle Laboratories King Avenue facility in Columbus, OH, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Battelle Laboratories King Avenue Location: Columbus, Ohio. Job Titles and/or Job Duties: All Atomic Weapons Employees who worked at the King Avenue facility in Columbus, Ohio. Period of Employment: April 16, 1943 through June 30, 1956.
Blood Products Advisory Committee; Notice of Meeting
Document Number: 2012-27323
Type: Notice
Date: 2012-11-08
Agency: Food and Drug Administration, Department of Health and Human Services
National Advisory Council on Migrant Health; Notice of Meeting
Document Number: 2012-27312
Type: Notice
Date: 2012-11-08
Agency: Department of Health and Human Services, Health Resources and Services Administration
Meeting of the Advisory Committee on Blood and Tissue Safety and Availability
Document Number: 2012-27307
Type: Notice
Date: 2012-11-08
Agency: Department of Health and Human Services
As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will hold a meeting. The meeting will be open to the public.
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2012-27268
Type: Notice
Date: 2012-11-08
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Document Number: 2012-27267
Type: Notice
Date: 2012-11-08
Agency: Department of Health and Human Services, National Institutes of Health
Draft Compliance Policy Guide Sec. 550.050 Canned Ackee, Frozen Ackee, and Other Ackee Products-Hypoglycin A Toxin; Availability
Document Number: 2012-27225
Type: Notice
Date: 2012-11-08
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing the availability of a draft Compliance Policy Guide entitled ``Compliance Policy Guide Sec. 550.050 Canned Ackee, Frozen Ackee, and Other Ackee ProductsHypoglycin A Toxin (the draft CPG).'' The draft CPG, when finalized, will provide guidance for FDA staff on our enforcement criteria for canned ackee, frozen ackee, and other ackee products that contain hypoglycin A.
Medicare Program; Home Health Prospective Payment System Rate Update for Calendar Year 2013, Hospice Quality Reporting Requirements, and Survey and Enforcement Requirements for Home Health Agencies
Document Number: 2012-26904
Type: Rule
Date: 2012-11-08
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This final rule updates the Home Health Prospective Payment System (HH PPS) rates, including the national standardized 60-day episode rates, the national per-visit rates, the low-utilization payment amount (LUPA), the non-routine medical supplies (NRS) conversion factor, and outlier payments under the Medicare prospective payment system for home health agencies effective January 1, 2013. This rule also establishes requirements for the Home Health and Hospice quality reporting programs. This final rule will also establish requirements for unannounced, standard and extended surveys of home health agencies (HHAs) and sets forth alternative sanctions that could be imposed instead of, or in addition to, termination of the HHA's participation in the Medicare program, which could remain in effect up to a maximum of 6 months, until an HHA achieves compliance with the HHA Conditions of Participation (CoPs) or until the HHA's provider agreement is terminated.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.